NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Nebulized Bupivacaine Analgesia for Cleft Palate Repair

RecruitingPhase 3

Sponsor: Assiut University

Conditions: Cleft Palate

Interventions: Bupivacaine Hydrochloride, 0.9% saline

Countries: Egypt

In this study we introduce a potent local anesthetic; bupivacaine 0.5% in 0.5 mg/kg dose by nebulization as a preemptive analgesia to compare efficacy and safety in children with cleft palate repair.

Eligibility overview

Sex: ALL

Age: 1 Year to 7 Years

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Children (age 1-7 years) of American Society of Anaesthesiologists physical status (ASA) I-II
* Elective cleft palate repair ± cleft lip surgery under general anesthesia .

Exclusion Criteria:

* Coronary artery disease
* Hypertension
* Developmental delay
* Allergy to study drug

Locations (1)

Asyut, Assuit, Egypt